Effect of acetylcholine on the highly stenotic coronary artery: difference between the constrictor response of the infarct-related coronary artery and that of the noninfarct-related artery
K Okumura,
H Yasue,
K Matsuyama,
H Ogawa,
Y Morikami,
K Obata,
and
N Sakaino
Division of Cardiology, Kumamoto University Medical School, Japan.
To examine the constrictor response of the infarct-related stenotic coronary artery in comparison with that of noninfarct-related stenotic arteries, acetylcholine in maximal doses of 100 micrograms for the left and 50 micrograms for the right coronary artery was injected into the 16 infarct-related coronary arteries of 16 patients with previous myocardial infarction (group 1) and into 19 stenotic coronary arteries of 16 patients with stable angina without myocardial infarction (group 2). Acetylcholine's effects on lumen diameter and area were quantitatively analyzed at the stenotic segment and its proximal segment without significant stenosis. Acetylcholine decreased lumen diameter and area at the stenotic segments from 0.72 +/- 0.18 to 0.18 +/- 0.33 mm and from 0.45 +/- 0.22 to 0.10 +/- 0.22 mm2, respectively, in group 1 (both p less than 0.01) and from 0.75 +/- 0.22 to 0.49 +/- 0.30 mm and 0.48 +/- 0.29 to 0.26 +/- 0.23 mm2, respectively, in group 2 (both p less than 0.01). Acetylcholine decreased the diameter and area at the proximal segment from 2.71 +/- 0.75 to 2.38 +/- 0.6 mm and from 6.18 +/- 3.4 to 4.71 +/- 2.23 mm2, respectively, in group 1 (both p less than 0.01) and from 2.31 +/- 0.67 to 1.95 +/- 0.59 mm and from 4.5 +/- 2.97 to 3.22 +/- 1.96 mm2, respectively, in group 2 (both p less than 0.01). The changes in diameter and area at the stenotic segment in group 1 were significantly greater than those in group 2 (both p less than 0.01); there were no significant differences between groups in the changes at the proximal segment.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:

|
 |

|
 |
 
J. E. Deanfield, J. P. Halcox, and T. J. Rabelink
Endothelial Function and Dysfunction: Testing and Clinical Relevance
Circulation,
March 13, 2007;
115(10):
1285 - 1295.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Waxman, F. Ishibashi, and J. E. Muller
Detection and Treatment of Vulnerable Plaques and Vulnerable Patients: Novel Approaches to Prevention of Coronary Events
Circulation,
November 28, 2006;
114(22):
2390 - 2411.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. K. Mishra
Variations in presentation and various options in management of variant angina
Eur J Cardiothorac Surg,
May 1, 2006;
29(5):
748 - 759.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Heiss, T. Lauer, A. Dejam, P. Kleinbongard, S. Hamada, T. Rassaf, S. Matern, M. Feelisch, and M. Kelm
Plasma Nitroso Compounds Are Decreased in Patients With Endothelial Dysfunction
J. Am. Coll. Cardiol.,
February 7, 2006;
47(3):
573 - 579.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Patti, V. Pasceri, R. Melfi, C. Goffredo, M. Chello, A. D'Ambrosio, R. Montesanti, and G. Di Sciascio
Impaired Flow-Mediated Dilation and Risk of Restenosis in Patients Undergoing Coronary Stent Implantation
Circulation,
January 4, 2005;
111(1):
70 - 75.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Brevetti, A. Silvestro, V. Schiano, and M. Chiariello
Endothelial Dysfunction and Cardiovascular Risk Prediction in Peripheral Arterial Disease: Additive Value of Flow-Mediated Dilation to Ankle-Brachial Pressure Index
Circulation,
October 28, 2003;
108(17):
2093 - 2098.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Widlansky, N. Gokce, J. F. Keaney Jr, and J. A. Vita
The clinical implications of endothelial dysfunction
J. Am. Coll. Cardiol.,
October 1, 2003;
42(7):
1149 - 1160.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Vita and J. F. Keaney Jr
Endothelial Function: A Barometer for Cardiovascular Risk?
Circulation,
August 6, 2002;
106(6):
640 - 642.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Iraculis, A. Cequier, J. A. Gomez-Hospital, M. Sabate, J. Mauri, E. Fernandez-Nofrerias, B. Garcia del Blanco, F. Jara, and E. Esplugas
Early dysfunction and long-term improvement in endothelium-dependent vasodilation in the infarct-related artery after thrombolysis
J. Am. Coll. Cardiol.,
July 17, 2002;
40(2):
257 - 265.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Pristipino, J. F. Beltrame, M. L. Finocchiaro, R. Hattori, M. Fujita, R. Mongiardo, D. Cianflone, T. Sanna, S. Sasayama, and A. Maseri
Major Racial Differences in Coronary Constrictor Response Between Japanese and Caucasians With Recent Myocardial Infarction
Circulation,
March 14, 2000;
101(10):
1102 - 1108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Beltrame, S. Sasayama, and A. Maseri
Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and caucasian patients
J. Am. Coll. Cardiol.,
May 1, 1999;
33(6):
1442 - 1452.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Marchioli, R. M. Marfisi, F. Carinci, and G. Tognoni
Meta-analysis, Clinical Trials, and Transferability of Research Results Into Practice: The Case of Cholesterol-Lowering Interventions in the Secondary Prevention of Coronary Heart Disease
Arch Intern Med,
June 10, 1996;
156(11):
1158 - 1172.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
G. N. Levine, B. Frei, S. N. Koulouris, M. D. Gerhard, J. F. Keaney Jr, and J. A. Vita
Ascorbic Acid Reverses Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease
Circulation,
March 15, 1996;
93(6):
1107 - 1113.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Gerhard and P. Ganz
How Do We Explain the Clinical Benefits of Estrogen? : From Bedside to Bench
Circulation,
July 1, 1995;
92(1):
5 - 8.
[Full Text]
|
 |
|
|